Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage I and II endometrial cancer—a multicentre, open, controlled, prospectively randomised trial

✍ Scribed by G. von Minckwitz; S. Loibl; K. Brunnert; R. Kreienberg; F. Melchert; R. Mösch; M. Neises; J. Schermann; R. Seufert; R. Stiglmayer; U. Stosiek; M. Kaufmann

• Book ID: 117659101
• Publisher: Elsevier Science
• Year: 2002
• Tongue: English
• Weight: 121 KB
• Volume: 38
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/s0959-8049(02)00378-7